Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neurogenetics

Showing results (71-80 of 1,080) with videos related to

Pageof 108
Sort By:
Neurogenetics|December 14, 1999
The human glia maturation factor-gamma gene: genomic structure and mutation analysis in gliomas with chromosome 19q lossN Peters, J S Smith, I Tachibana, et al.
Neurogenetics|December 14, 1999
Potential treatment of transthyretin-type amyloidoses by sulfiteK Altland, P Winter
Neurogenetics|December 14, 1999
The alpha-synuclein gene is not a major risk factor in familial Parkinson diseaseW K Scott, L H Yamaoka, J M Stajich, et al.
Neurogenetics|September 13, 2000
Parkinson disease: analysis of mitochondrial DNA in monozygotic twinsS Kösel, E M Grasbon-Frodl, J M Hagenah, et al.
Neurogenetics|September 13, 2000
Aceruloplasminemia with a novel mutation associated with parkinsonismS Kohno, H Miyajima, Y Takahashi, et al.
Neurogenetics|November 14, 2017
ARHGEF9 mutations in epileptic encephalopathy/intellectual disability: toward understanding the mechanism underlying phenotypic variationJing-Yang Wang, Peng Zhou, Jie Wang, et al.
Neurogenetics|December 20, 2018
Sudden unexpected death with rare compound heterozygous variants in PRICKLE1Yukiko Hata, Koji Yoshida, Naoki Nishida
Neurogenetics|December 7, 2017
Clinical application of next generation sequencing in hereditary spinocerebellar ataxia: increasing the diagnostic yield and broadening the ataxia-spasticity spectrum. A retrospective analysisDaniele Galatolo, Alessandra Tessa, Alessandro Filla, et al.
Neurogenetics|December 14, 2019
Whole exome sequencing reveals a broader variant spectrum of Charcot-Marie-Tooth disease type 2Shan Lin, Liu-Qing Xu, Guo-Rong Xu, et al.
Neurogenetics|March 18, 2018
In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)C Ranieri, S Di Tommaso, D C Loconte, et al.
Pageof 108

Showing results (71-80 of 1,080) with videos related to

Sort By:
Pageof 108
Neurogenetics|December 14, 1999
The human glia maturation factor-gamma gene: genomic structure and mutation analysis in gliomas with chromosome 19q lossN Peters, J S Smith, I Tachibana, et al.
Neurogenetics|December 14, 1999
Potential treatment of transthyretin-type amyloidoses by sulfiteK Altland, P Winter
Neurogenetics|December 14, 1999
The alpha-synuclein gene is not a major risk factor in familial Parkinson diseaseW K Scott, L H Yamaoka, J M Stajich, et al.
Neurogenetics|September 13, 2000
Parkinson disease: analysis of mitochondrial DNA in monozygotic twinsS Kösel, E M Grasbon-Frodl, J M Hagenah, et al.
Neurogenetics|September 13, 2000
Aceruloplasminemia with a novel mutation associated with parkinsonismS Kohno, H Miyajima, Y Takahashi, et al.
Neurogenetics|November 14, 2017
ARHGEF9 mutations in epileptic encephalopathy/intellectual disability: toward understanding the mechanism underlying phenotypic variationJing-Yang Wang, Peng Zhou, Jie Wang, et al.
Neurogenetics|December 20, 2018
Sudden unexpected death with rare compound heterozygous variants in PRICKLE1Yukiko Hata, Koji Yoshida, Naoki Nishida
Neurogenetics|December 7, 2017
Clinical application of next generation sequencing in hereditary spinocerebellar ataxia: increasing the diagnostic yield and broadening the ataxia-spasticity spectrum. A retrospective analysisDaniele Galatolo, Alessandra Tessa, Alessandro Filla, et al.
Neurogenetics|December 14, 2019
Whole exome sequencing reveals a broader variant spectrum of Charcot-Marie-Tooth disease type 2Shan Lin, Liu-Qing Xu, Guo-Rong Xu, et al.
Neurogenetics|March 18, 2018
In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)C Ranieri, S Di Tommaso, D C Loconte, et al.
Pageof 108